PDS Biotechnology Files 8-K
Ticker: PDSB · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
PDS Biotech filed an 8-K on March 13, 2025, for routine corporate updates.
AI Summary
PDS Biotechnology Corporation filed an 8-K on March 13, 2025, reporting on other events and financial statements. The company, formerly known as Edge Therapeutics, Inc., is incorporated in Delaware and headquartered in Princeton, NJ.
Why It Matters
This filing indicates routine corporate reporting, providing updates on company events and financial disclosures for investors and regulatory bodies.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for corporate events and financial statements, not indicating any specific new risks.
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- Edge Therapeutics, Inc. (company) — Former Company Name
- March 13, 2025 (date) — Date of Report
- Princeton, NJ (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of March 13, 2025.
What is the exact name of the registrant?
The exact name of the registrant is PDS Biotechnology Corporation.
When was PDS Biotechnology Corporation incorporated?
PDS Biotechnology Corporation was incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive office is located at 303A College Road East, Princeton, NJ 08540.
What was the company's former name?
The company's former name was Edge Therapeutics, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding PDS Biotechnology Corp (PDSB).